Serum Glial Fibrillary Acidic Protein in Acute Stroke

被引:0
作者
David B. Seder
机构
[1] Tufts University School of Medicine,Department of Critical Care Services, Maine Medical Center
来源
Neurocritical Care | 2020年 / 33卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:35 / 36
页数:1
相关论文
共 32 条
[1]  
Brunkhorst R(2010)Astroglial proteins as diagnostic markers of acute intracerebral hemorrhage-pathophysiological background and clinical findings Transl Stroke Res 1 246-251
[2]  
Pfeilschifter W(2012)Diagnostic accuracy of plasma glial fibrillary acidic protein for differentiating intracerebral hemorrhage and cerebral ischemia in patients with symptoms of acute stroke Clin Chem 58 237-245
[3]  
Foerch C(2009)Characterisation of the diagnostic window of serum glial fibrillary acidic protein for the differentiation of intracerebral haemorrhage and ischaemic stroke Cerebrovasc Dis 27 37-41
[4]  
Foerch C(2007)Serum GFAP is a diagnostic marker for glioblastoma multiforme Brain 130 3336-3341
[5]  
Niessner M(2013)Blood levels of glial fibrillary acidic protein (GFAP) in patients with neurological diseases PLoS ONE 8 e62101-560
[6]  
Back T(2016)Time course and diagnostic accuracy of glial and neuronal blood biomarkers GFAP and UCH-L1 in a large cohort of trauma patients with and without mild traumatic brain injury JAMA Neurol 73 551-85
[7]  
Dvorak F(2005)Recombinant activated factor VII intracerebral hemorrhage trial investigators. Recombinant activated factor VII for acute intracerebral hemorrhage N Engl J Med 352 777-37
[8]  
Haberer I(2008)FAST trial investigators. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage N Engl J Med 358 2127-1723
[9]  
Sitzer M(2019)Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial Lancet 394 1713-1752
[10]  
Foerch C(2018)Management of comatose survivors of cardiac arrest Continuum (Minneap Minn) 24 1732-71